Bausch & Lomb Inc - Company Profile
Powered by
All the data and insights you need on Bausch & Lomb Inc in one report.
- Save hours of research time and resources with
our up-to-date Bausch & Lomb Inc Strategy Report
- Understand Bausch & Lomb Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Bausch & Lomb Inc (Bausch & Lomb), a subsidiary of Bausch Health Companies Inc, is a vision-care company with focus on the protection, enhancement and restoration of eyesight. It provides over-the-counter supplements, eye care products, contact lenses, ophthalmic pharmaceuticals, lens care products, ophthalmic surgical devices and instruments. The company develops, manufactures and markets eye health products for the treatment of a wide range of eye conditions such as conjunctivitis, glaucoma, eye allergies, dry eye and retinal diseases. It has presence across the Americas, Europe, the Middle East, Africa and Asia-Pacific. Bausch & Lomb is headquartered in Bridgewater, New Jersey, the US.
Bausch & Lomb Inc premium industry data and analytics
Products and Services
Products | Brands |
---|---|
Products | PreserVision |
Contact Lenses: | Ocuvite |
Lenses for Nearsighted/Farsighted | Lotemax |
XYZ | XYZ |
XYZ | XYZ |
XYZ | XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
Year | Event | Description |
---|---|---|
2023 | Asset Purchase | In September, the company acquired 'front of eye' ophthalmology assets from Novartis. |
2023 | Acquisitions/Mergers/Takeovers | In July, the company acquired Johnson & Johnson eye and contact lens drops brand, Blink for US$106.5 million. |
2023 | Contracts/Agreements | In July, the company signed an agreement to acquire dry eye drug Xiidra from Novartis. |
Competitor Comparison
Key Parameters | Bausch & Lomb Inc | EssilorLuxottica SA | Carl Zeiss Meditec AG | Harrow Inc | Abbott Medical Optics Inc |
---|---|---|---|---|---|
Headquarters | United States of America | France | Germany | United States of America | United States of America |
City | Bridgewater | Charenton-Le-Pont | Jena | Nashville | Santa Ana |
State/Province | New Jersey | Ile-de-France | Thuringen | Tennessee | California |
No. of Employees | 12,000 | 191,706 | 4,950 | 315 | - |
Entity Type | Private | Public | Public | Public | Private |
Executives
Name | Position | Board | Since | Age |
---|---|---|---|---|
Brent Saunders | Chairman; Chief Executive Officer | Executive Board | 2023 | - |
Bob Bailey | Executive Vice President; Chief Legal Officer | Senior Management | 2023 | - |
Sam Eldessouky | Executive Vice President; Chief Financial Officer | Senior Management | - | - |
Yehia Hashad | Executive Vice President - Research & Development; Chief Medical Officer | Senior Management | - | - |
Dennis Asharin | Supply Chain Officer; Executive Vice President; Chief Global Manufacturing | Senior Management | - | - |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer